Open Multicenter Phase II Study in Second-Line Metastatic Colorectal Cancer Patients: Combination of ALIMTA and Irinotecan Administered Every Two-Weeks.
Phase of Trial: Phase II
Latest Information Update: 04 Jan 2011
At a glance
- Drugs Irinotecan; Pemetrexed
- Indications Colorectal cancer
- Focus Therapeutic Use
- 11 Jun 2008 Status change from in progress to completed, according to clinicaltrials.gov.
- 28 Jul 2006 Status change
- 02 Nov 2005 New trial record.